149 related articles for article (PubMed ID: 37642056)
1. Pretreatment Microvessel Density for Predicting of Tumor Responsiveness to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.
Boonya-Ussadorn C; Nimmanon T; Anannamcharoen S
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2697-2703. PubMed ID: 37642056
[TBL] [Abstract][Full Text] [Related]
2. Tissue Microvessel Density as a Potential Predictive Marker for Vascular Invasion in Colorectal Cancer.
Anannamcharoen S; Boonya-Ussadorn C; Nimmanon T
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4097-4102. PubMed ID: 38156843
[TBL] [Abstract][Full Text] [Related]
3. Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density.
Xu Y; Lou X; Liang Y; Zhang S; Yang S; Chen Q; Xu Z; Zhao M; Li Z; Zhao K; Liu Z
J Inflamm Res; 2021; 14():5891-5899. PubMed ID: 34785927
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
6. Response assessment of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Is apparent diffusion coefficient useful on 3 T magnetic resonance imaging?
Boraschi P; Cervelli R; Donati F; Landi E; Cacciato-Insilla A; Campani D; Caramella D
Colorectal Dis; 2023 May; 25(5):905-915. PubMed ID: 36638020
[TBL] [Abstract][Full Text] [Related]
7. [Expression of CD133 in rectal cancer tissues and its relationship with neoadjuvant chemoradiotherapy].
Li D; Wu H; Feng R; Zhong D; Luo Y; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):690-4. PubMed ID: 27353106
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and Therapeutic Potential Implications of Genetic Variability in Prostaglandin E2 Pathway Genes in Rectal Cancer.
Santos MD; Silva C; Rocha A; Nogueira C; Castro-Poças F; Araujo A; Matos E; Pereira C; Medeiros R; Lopes C
Anticancer Res; 2017 Jan; 37(1):281-291. PubMed ID: 28011504
[TBL] [Abstract][Full Text] [Related]
10. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
11. Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.
Repetto O; De Re V; De Paoli A; Belluco C; Alessandrini L; Canzonieri V; Cannizzaro R
Oncotarget; 2017 Apr; 8(17):28328-28341. PubMed ID: 28423701
[TBL] [Abstract][Full Text] [Related]
12. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).
Crimì F; Capelli G; Spolverato G; Bao QR; Florio A; Milite Rossi S; Cecchin D; Albertoni L; Campi C; Pucciarelli S; Stramare R
Radiol Med; 2020 Dec; 125(12):1216-1224. PubMed ID: 32410063
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
14. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G
Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
[TBL] [Abstract][Full Text] [Related]
15. Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Marinkovic M; Stojanovic-Rundic S; Stanojevic A; Ostojic M; Gavrilovic D; Jankovic R; Maksimovic N; Stroggilos R; Zoidakis J; Castellví-Bel S; Fijneman RJA; Cavic M
Front Genet; 2023; 14():1245594. PubMed ID: 37719698
[No Abstract] [Full Text] [Related]
16. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
[TBL] [Abstract][Full Text] [Related]
17. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
18. Predictive clinical model of tumor response after chemoradiation in rectal cancer.
Santos MD; Silva C; Rocha A; Nogueira C; Castro-Poças F; Araujo A; Matos E; Pereira C; Medeiros R; Lopes C
Oncotarget; 2017 Aug; 8(35):58133-58151. PubMed ID: 28938543
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
20. The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study.
Liang Y; Zhu Y; Lin H; Zhang S; Li S; Huang Y; Liu C; Qu J; Liang C; Zhao K; Li Z; Liu Z
BMC Cancer; 2021 Jun; 21(1):729. PubMed ID: 34172021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
